Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Jacob

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Drugs|May 27, 2004
The management of hypertension in the overweight and obese patient: is weight reduction sufficient?Stephan Jacob
MMW Fortschritte Der Medizin|July 17, 2007
[New rank order of antidiabetic drugs. Using glitazone before sulfonylurea drugs? (interview by Dr. Dirk Einecke)]Stephan Jacob
Deutsche Medizinische Wochenschrift (1946)|April 15, 2016
[Insulin therapy: as late as possible]Stephan Jacob
MMW Fortschritte Der Medizin|November 7, 2019
[Prevention of CV complications in DM2 - which targets should be used?]Stephan Jacob
MMW Fortschritte Der Medizin|March 30, 2005
[Patient with beer belly or hypertension. Check for a metabolic syndrome!]Stephan Jacob
Deutsche Medizinische Wochenschrift (1946)|March 21, 2014
[Diabetes type 2: does intensive glycaemic control provides advantages?]Stephan Jacob
Journal of Cellular Physiology|May 27, 2003
Modulation of metabolic control by angiotensin converting enzyme (ACE) inhibitionErik J Henriksen, Stephan Jacob
Cardiovascular Endocrinology & Metabolism|February 28, 2020
Exercise prescription in patients with type 2 diabetes and coronary heart disease: could less be more?Stephan Jacob, Andrew J Krentz
Journal of Clinical Hypertension (Greenwich, Conn.)|December 16, 2004
Metabolic properties of vasodilating beta blockers: management considerations for hypertensive diabetic patients and patients with the metabolic syndromeStephan Jacob, Erik J Henriksen
Cardiovascular Endocrinology & Metabolism|October 8, 2019
Cardiometabolic medicine: time to recognize a new clinical specialty?Andrew J Krentz, Stephan Jacob
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Drugs|May 27, 2004
The management of hypertension in the overweight and obese patient: is weight reduction sufficient?Stephan Jacob
MMW Fortschritte Der Medizin|July 17, 2007
[New rank order of antidiabetic drugs. Using glitazone before sulfonylurea drugs? (interview by Dr. Dirk Einecke)]Stephan Jacob
Deutsche Medizinische Wochenschrift (1946)|April 15, 2016
[Insulin therapy: as late as possible]Stephan Jacob
MMW Fortschritte Der Medizin|November 7, 2019
[Prevention of CV complications in DM2 - which targets should be used?]Stephan Jacob
MMW Fortschritte Der Medizin|March 30, 2005
[Patient with beer belly or hypertension. Check for a metabolic syndrome!]Stephan Jacob
Deutsche Medizinische Wochenschrift (1946)|March 21, 2014
[Diabetes type 2: does intensive glycaemic control provides advantages?]Stephan Jacob
Journal of Cellular Physiology|May 27, 2003
Modulation of metabolic control by angiotensin converting enzyme (ACE) inhibitionErik J Henriksen, Stephan Jacob
Cardiovascular Endocrinology & Metabolism|February 28, 2020
Exercise prescription in patients with type 2 diabetes and coronary heart disease: could less be more?Stephan Jacob, Andrew J Krentz
Journal of Clinical Hypertension (Greenwich, Conn.)|December 16, 2004
Metabolic properties of vasodilating beta blockers: management considerations for hypertensive diabetic patients and patients with the metabolic syndromeStephan Jacob, Erik J Henriksen
Cardiovascular Endocrinology & Metabolism|October 8, 2019
Cardiometabolic medicine: time to recognize a new clinical specialty?Andrew J Krentz, Stephan Jacob
Pageof 5